Gene organization and evolutionary history
==========================================

Gene organization
-----------------

In humans, 19 *WNT* genes have been identified and the chromosomal locations of each is known (see Table [1](#T1){ref-type="table"}) \[[@B1],[@B2],[@B3],[@B4],[@B5],[@B6]\]. Several human *WNT* genes are located very close to each other in the genome \[[@B7],[@B8]\]; these include *WNT6* and *WNT10a,* which are located immediately adjacent to one another on chromosome 2 (about 6.4 kilobases (kb) apart), and *WNT1* and *WNT10b,* which are located adjacent to each other on chromosome 12 (about 8.1 kb apart). *WNT6* and *WNT10a* are transcribed in opposite directions, whereas *WNT1* and *WNT10b* are expressed from the same strand of DNA. Several additional pairs of *WNT* genes are also clustered within the human genome, including *WNT2* and *WNT16* (about 4 megabases (Mb) apart), *WNT3a* and *WNT14* (about 250 kb apart), and *WNT3* and *WNT15.* In the mouse, there are at least 18 *Wnt* genes and the locations of all but two of them have been determined \[[@B1],[@B2],[@B3],[@B5],[@B6]\]. As in humans, the mouse *Wnt1/Wnt10b, Wnt6/Wnt10a,* and *Wnt3/Wnt15* gene pairs are each located on the same chromosomes, and in the case of the *Wnt1/Wnt10b* and *Wnt6/Wnt10a* pairs the close proximity of these genes has been conserved from mouse to human. Interestingly, in the *Drosophila* genome, the paralogous genes *wingless (wg), DWnt6* and *DWnt10,* are located immediately adjacent to one another on the second chromosome and are all transcribed in the same orientation. Thus, it is possible that there was an ancient cluster of *Wnt* genes consisting of *Wnt1, Wnt6* and *Wnt10* in a common ancestor of vertebrates and arthropods. In vertebrates, this cluster may have been duplicated with subsequent loss of *Wnt1* from one cluster and *Wnt6* from the other.

###### 

Chromosomal locations of *WNT* genes in human and mouse

  Human         Mouse      References   Accession numbers^†^                                              
  ------------- ---------- ------------ ---------------------- --------------------- -------------------- ----------
  *WNT1*        12q13      *Wnt1*       15                     \[87-91\]             X03072               K02593
  *WNT2*        7q31       *Wnt2*       6 (4.2 cM)             \[92,93\]             X07876               AK012093
  *WNT2b/13*    1p13       *Wnt2b/13*   3 (49.0 cM)            \[94-96\]             XM052111, XM052112   AF070988
  *WNT3*        17q21      *Wnt3*       11 (63.0 cM)           \[97-100\]            AY009397             M32502
  *WNT3a*       1q42.13    *Wnt3a*      11 (32.0 cM)           \[101-103\]           AB060284             X56842
  *WNT4*        1p35       *Wnt4*       4                      \[100,104\]           AY009398             M89797
  *WNT5a*       3p14-p21   *Wnt5a*      14 (14.8 cM)           \[104-106\]           L20861               M89798
  *WNT5b*       12p13.3    *Wnt5b*      6 (56.2 cM)            \[104,107\]           AB060966             M89799
  *WNT6*        2q35       *Wnt6*       1                      \[104,107,108         AY009401             M89800
  *WNT7a*       3p25       *Wnt7a*      6 (39.5 cM)            \[104,106,110,111\]   D83175               M89801
  *WNT7b*       22q13.3    *Wnt7b*      15 (46.9 cM)           \[100,104,112,113\]   AB062766             M89802
  *WNT8a/d*     5q31       *Wnt8a*                             \[114,115\]           AB057725, AY009402   Z68889
  *WNT8b*       10q24      *Wnt8b*      19 (43.0 cM)           \[116-118\]           Y11094               AF130349
  *WNT10a*      2q35       *Wnt10a*     1                      \[109,119\]           AB059569             U61969
  *WNT10b/12*   12q13.1    *Wnt10b*     15 (56.8 cM)           \[106,119-124\]       U81787               U61970
  *WNT11*       11q13.5    *Wnt11*      7                      \[106,125\]           Y12692               X70800
  *WNT14*       1q42       \-                                  \[103,126\]           AB060283             
  *WNT15*       17q21      *Wnt15*      11                     \[126\]               AF028703             AF031169
  *WNT16*       7q31       *Wnt16*                             \[127,128\]           XM031374, XM004884   AF172064

^\*^Locations of mouse genes give the chromosome and the distance in centimorgans (cM) from the telomere. ^†^Accession numbers are for GenBank \[3\].

The majority of human *WNT* genes contain four coding exons, with exon 1 containing the initiation methionine (Figure [1a](#F1){ref-type="fig"}) \[[@B8]\]. *WNT* genes that differ from this pattern include *WNT14,* with three exons, *WNT2, WNT5b,* and *WNT11,* with five exons, and *WNT8b* with six exons. Several *WNTs - WNT2b/13, WNT8a/d,* and *WNT16* - have alternative amino or carboxyl termini, which result from the use of alternative 5\' or 3\' exons.

![**(a)** Structures of selected members of the human *WNT* gene family. Exons are shown as boxes and introns as lines. For each gene, \'RNA\' represents the portion of the gene that is transcribed and \'CDS\' represents the portion that encodes protein. *WNT8a/d* is an example of a gene with 3\' alternative splicing and *WNT16* is an example of a gene with alternatively used 5\' exons. **(b)** Structural features of the Wnt protein. The amino terminus contains a signal sequence (S). All Wnts contain 23 or 24 conserved cysteine residues (C) with similar spacing, suggesting that the folding of Wnt proteins depends on the formation of multiple intramolecular disulfide bonds.](gb-2001-3-1-reviews3001-1){#F1}

Evolutionary history
--------------------

The deduced evolutionary relationships of 18 of the 19 known human *WNT* genes are shown in Figure [2](#F2){ref-type="fig"}. The majority of Wnt proteins share about 35% amino-acid sequence identity, although members of a subgroup (those with the same numeral, such as *WNT3* and *WNT3a*) share increased sequence identity (from 58% to 83%) and some overlapping sites of expression. Members of subgroups are not closely linked within the genome, however, suggesting that they were generated by gene-translocation or genome-duplication events, not by local duplication events.

![Predicted evolutionary relationships between members of the *Wnt* gene family. **(a)** Predicted relationships between 18 of the 19 known human *WNT* protein sequences; *WNT15* was omitted because only a partial sequence is available. **(b)** Predicted evolutionary relationships between selected human *WNT* proteins (representing each large grouping shown in (a)) and *Wnt* proteins from mouse, *Xenopus, Drosophila,* and *Caenorhabditis elegans.* Sequences were aligned using the ClustalW program; trees were constructed from the alignments using the neighbor-joining method and are diagrammed using midpoint rooting. Numbers indicate branch lengths.](gb-2001-3-1-reviews3001-2){#F2}

*Wnt* genes have been identified in vertebrates and invertebrates, but appear to be absent from plants, unicellular eukaryotes such as *Saccharomyces cerevisiae* and from prokaryotes. To date, in vertebrates, 16 *Wnt* genes have been identified in *Xenopus,* 11 in chick, and 12 in zebrafish \[[@B5]\]; in invertebrates, *Drosophila* has seven *Wnt* genes, *Caenorhabditis elegans* five and *Hydra* at least one \[[@B5]\]. The apparent evolutionary relationships between selected invertebrate and vertebrate *Wnt* genes are shown in Figure [2b](#F2){ref-type="fig"}. In vertebrates, the orthologs in different species are highly similar in sequence. For example, human WNT1 and mouse Wnt1 are 98% identical, and human WNT3a and *Xenopus* Wnt5a are 84% identical at the amino-acid level. Phylogenetic analyses of vertebrate and invertebrate Wnts demonstrate orthologous relationships between several human and *Drosophila Wnts* (Figure [2b](#F2){ref-type="fig"}). The sequence identity between orthologous proteins in humans and flies ranges from 21% between human WNT8a/d and *Drosophila* DWnt8 to 42% sequence identity between human WNT1 and *Drosophila* Wingless (Wg). The evolutionary relationship between the five *C. elegans Wnt* genes and human *WNT* genes is less apparent, making it difficult to determine which *C. elegans Wnt* genes may have orthologs in the human genome.

Characteristic structural features
==================================

Human WNT proteins are all very similar in size, ranging in molecular weight from 39 kDa (WNT7a) to 46 kDa (WNT10a) \[[@B3]\]. *Drosophila* Wnt proteins are also similar to this, with the exception of Wg, which is approximately 54 kDa and has an internal insert not found in vertebrate Wnts, and DWnt3/5, which is about 112 kDa \[[@B3]\]. Very little is known about the structure of Wnt proteins, as they are notoriously insoluble, but all have 23 or 24 cysteine residues, the spacing of which is highly conserved (Figure [1b](#F1){ref-type="fig"}), suggesting that Wnt protein folding may depend on the formation of multiple intramolecular disulfide bonds. Analysis of the signaling activities of chimeric Wnt proteins has shown that the carboxy-terminal region of Wnt proteins may play a role in determining the specificity of responses to different Wnts \[[@B9]\]. Furthermore, deletion mutants lacking the carboxy-terminal third of a Wnt protein can act as dominant-negatives in a cell-non-autonomous manner \[[@B10]\], suggesting that the amino-terminal region may mediate interactions with Wnt receptors but requires the carboxyl terminus to activate these receptors.

Localization and function
=========================

Post-translational modifications and secretion
----------------------------------------------

Wnt proteins have an amino-terminal signal sequence, can act in a cell non-autonomous manner, and are present in the secretory pathway, indicating that they are secreted proteins \[[@B11]\]. In addition, genetic analyses of Wg signaling in *Drosophila* uncovered mutations in the *porcupine* gene that show a lack of Wnt activity due to the retention of Wg protein in the endoplasmic reticulum \[[@B12],[@B13],[@B14]\]. The *porcupine* gene is predicted to encode a protein with eight transmembrane domains and has a perinuclear localization in transfected cells \[[@B14]\]; overexpression of *porcupine* does not increase levels of secreted Wg but does change the pattern of Wg glycosylation \[[@B14]\]. In worms, *mom-1* encodes a *porcupine* homolog and, when mutated, phenocopies mutants of *mom-2,* which encodes a Wnt, suggesting that the function of *porcupine* is conserved \[[@B15],[@B16]\]. Although size chromatography suggests that Wg is secreted as a multimer, it remains unclear whether Wnt proteins in general are secreted as monomers, oligomers, or as part of a multi-protein complex \[[@B17]\]. Wnt proteins are glycosylated, but mutation of some or all of the predicted glycosylation sites in mouse Wnt1 does not abolish its activity in cultured cells \[[@B18]\]; these modifications may thus be unimportant for Wnt function.

Subcellular localization
------------------------

Once secreted, Wnt proteins associate with glycosaminoglycans in the extracellular matrix and are bound tightly to the cell surface \[[@B19],[@B20]\]. Although Wnts are found in tight association with the plasma membrane, it is possible to collect active Wnt from the medium of cultured cells \[[@B21],[@B22]\]. Beyond this information, the localization of Wnt proteins in vertebrates is poorly understood. Examination of the localization of Wg in *Drosophila,* however, has provided critical insights into the subcellular distribution of Wnt proteins and the importance of this distribution for signaling activity. In the embryonic epidermis, Wg is found inside cells that secrete Wg and in association with the plasma membrane of secreting cells and non-secreting cells several cell diameters from the Wg source \[[@B23]\]. Wg is also prevalent in vesicles and multi-vesicular bodies of non-Wg-producing cells anterior to the source of Wg, suggesting that Wg is endocytosed \[[@B23],[@B24]\]. This idea is supported by examination of *shibire* embryos, which have a mutation in dynamin, a critical component of the endocytic machinery; these mutants have defects in Wg distribution, and Wg signaling activity is compromised \[[@B25]\]. Similarly, expression of a dominant-negative form of *shibire* also reduces Wg activity \[[@B26]\]. Endocytosis may also help to limit the distribution of Wg signal. In contrast to cells anterior to the Wg source, cells posterior to Wg-producing cells have much lower levels of Wg in endocytic vesicles, and this asymmetry in distribution mirrors the observation that Wg acts over a much shorter range towards the posterior than towards the anterior. This difference in Wg distribution appears to be due to rapid degradation of endocytosed Wg in posterior cells \[[@B27]\]. The spatially restricted pattern of Wg degradation is regulated by signals through the epidermal growth factor (EGF) receptor that hasten the destruction of Wg in posterior cells \[[@B27]\].

Association of Wg with specific membrane microdomains also appears to play a role in controlling the distribution of Wg signals during *Drosophila* development. In imaginal discs, Wg is found in specialized membrane vesicles called argosomes, which are thought to be derived from lipid raft microdomains \[[@B28]\]. Incorporation of Wg into argosomes requires heparan sulfate proteoglycans, suggesting that proteoglycans play a role in sorting Wg to specialized membrane microdomains in Wg-producing cells or, alternatively, may play a role localizing Wg in distinct endocytic compartments in receiving cells.

Polarized distribution of *wg* transcripts in embryonic epithelial cells is also required for optimal signaling activity. High-resolution *in situ* hybridization analyses demonstrate that *wg* transcripts are localized apically in the embryonic epidermis and that this distribution is mediated by two *cis*-acting elements found in the 3\' UTR of the *wg* mRNA \[[@B29]\]. Mutation of these elements results in uniform localization of *wg* transcripts and impaired Wg protein distribution and signaling. The asymmetric distribution of *wg* transcripts is dependent on dynein-mediated microtubule transport \[[@B30]\].

Function
--------

### Wnts and Wnt receptors

Reception and transduction of Wnt signals involves binding of Wnt proteins to members of two distinct families of cell-surface receptors, members of the Frizzled (Fzd) gene family and members of the LDL-receptor-related protein (LRP) family \[[@B31],[@B32]\]. The canonical Fzd receptor has an amino-terminal cysteine-rich domain (CRD) that binds Wnt, seven transmembrane domains and a short cytoplasmic tail containing a consensus PDZ domain binding motif (S/T-X-V in the single-letter amino-acid code) at the carboxyl terminus. The CRD forms a novel protein fold with a conserved dimerization interface that may be important for Wnt binding \[[@B33]\]. Fzd receptors have been identified in vertebrates and invertebrates; there are ten known members in humans and mice, four in flies, and three in worms. The general structure of Fzd receptors resembles that of seven-transmembrane G-protein-coupled receptors, suggesting that Fzd proteins may use heterotrimeric G proteins to transduce Wnt signals. Several recent studies provide evidence consistent with this idea, showing that a subgroup of Fzd receptors can signal through the pertussis-toxin-sensitive subclass of heterotrimeric G proteins to stimulate an increase in intracellular Ca^2+^ and activate protein kinase C (PKC) \[[@B34],[@B35],[@B36],[@B37],[@B38]\]. Heterotrimeric G proteins do not appear to be involved in transducing Wnt/Fzd signals that regulate the cytoskeleton-associated protein (β-catenin, however (see below).

Two members of the vertebrate LRP family, LRP-5 and LRP-6, can bind Wnts and may form a ternary complex with a Wnt and a Fzd \[[@B39]\]. Mutations in *LRP-6* in mice result in developmental defects similar to those seen in mice deficient for several individual *Wnt* genes \[[@B40]\], and overexpression of LRP in *Xenopus* can activate the Wnt pathway \[[@B39]\]. In *Drosophila, arrow,* the ortholog of LRP5 and LRP6, is required for optimal Wg signaling \[[@B41]\]. Although the mechanism of LRP signaling is unclear, recent evidence suggests that binding of the cytoplasmic domain of LRP to the Wnt antagonist Axin may play a role in Wnt pathway activation \[[@B42]\].

In addition to the Fzd and LRP receptors, cell-surface proteoglycans also appear to have a role in the reception of Wnt signals. For example, genetic analyses in *Drosophila* have shown that several genes required for optimal Wg signaling encode cell-surface proteoglycans of the glypican family \[[@B43],[@B44]\] and proteins involved in proteoglycan synthesis \[[@B45],[@B46],[@B47]\]. Furthermore, QSulf1, an avian protein related to heparan-specific *N*-acetyl glucosamine sulfatases, has also been shown to regulate heparan-dependent Wnt signaling in cultured cells \[[@B48]\]. It is unclear at this time how proteoglycans modulate Wnt signaling, but current suggestions include concentrating Wnt proteins at the cell surface or presenting Wnt ligands to cell-surface receptors.

### Secreted modulators of Wnt signaling

Wnt signals are modulated extracellularly by diverse secreted proteins, including members of the Frizzled-related protein (FRP or FrzB) family \[[@B49]\], Wnt-inhibitory factor-1 (WIF-1) \[[@B50]\], Cerberus \[[@B51]\], and Dickkopf (Dkk) \[[@B52]\]. FRPs, WIF-1, and Cerberus can bind Wnt proteins directly and are thought to antagonize Wnt function by preventing their interaction with Fzd receptors. FRPs can also interact with Fzds, suggesting that a second way in which FRPs might antagonize Wnt signaling is through the formation of a nonfunctional complex with Fzd receptors. Humans have at least five *FRP* genes, and the specificity of each FRP for different Wnts remains to be determined. Dkk does not bind Wnts but instead interacts with the extracellular domain of LRPs, thereby blocking activation of Wnt signaling \[[@B42],[@B53],[@B54]\]. Four *Dkk* genes have been identified in vertebrates, including *Dkk2,* which does not act as a Wnt antagonist but rather can stimulate Wnt signaling \[[@B55]\].

### Intracellular signaling pathways

Wnt signals are transduced through at least three distinct intracellular signaling pathways including the canonical \'Wnt/β-catenin\' pathway, the \'Wnt/Ca^2+^\' pathway, and the \'Wnt/polarity\' pathway (also called the \'planar polarity\' pathway) \[[@B5],[@B56],[@B57],[@B58],[@B59],[@B60],[@B61],[@B62]\]. Distinct sets of Wnt and Fzd ligand-receptor pairs can activate each of these pathways and lead to unique cellular responses. The Wnt/β-catenin pathway primarily regulates cell fate determination during development, whereas the major function of the Wnt/polarity pathway is regulation of cytoskeletal organization. The biological function of the Wnt/Ca^2+^ pathway is unclear.

The canonical Wnt/β-catenin pathway is intensely studied, and on the basis of current literature I propose the model illustrated in Figure [3a](#F3){ref-type="fig"} \[[@B59],[@B63],[@B64]\]. Signaling through this pathway depends on the levels of β-catenin in the cell. In the absence of Wnt, β-catenin is targeted for degradation by a multi-protein destruction complex. Wnt signaling antagonizes the destruction complex, leading to the accumulation of β-catenin and activation of target genes. Up-to-date lists of proteins involved in Wnt/β-catenin signaling and the potential roles of each of these proteins can be found on the worldwide web \[[@B5],[@B60],[@B62]\].

![The known Wnt signaling pathways. **(a)** In the Wnt/β-catenin pathway, Wnt signaling depends on the steady-state levels of the multi-functional protein β-catenin. In the absence of Wnt signal, a multi-protein destruction complex that includes the adenomatous polyposis coli protein (APC) and a member of the Axin family facilitates the phosphorylation of β-catenin by glycogen synthase kinase 3 (GSK3). GSK3 substrates also include APC and Axin; phosphorylation of each of these proteins leads to enhanced binding of β-catenin. Phosphorylated β-catenin is bound by the F-box protein β-TrCP, a component of an E3 ubiquitin ligase complex, and is ubiquitinated; the ubiquitin tag marks β-catenin for destruction by the proteasome. When a cell is exposed to a Wnt, the Wnt interacts with its coreceptors Frizzled and LRP. Activation of Frizzled and LRP leads to the phosphorylation of Dishevelled (Dsh), a cytoplasmic scaffold protein, perhaps through stimulation of casein kinase Iε (CKIε) and/or casein kinase II (CKII). Dsh then functions through its interaction with Axin to antagonize GSK3, preventing the phosphorylation and ubiquitination of β-catenin. In vertebrates, inhibition of GSK3 may involve the activity of GSK3 binding protein (GBP/Frat), which binds to both Dsh and GSK3 and can promote dissociation of GSK3 from the destruction complex. Unphosphorylated β-catenin escapes degradation, accumulates in the cell, and enters the nucleus, where it interacts with members of the TCF/LEF family of HMG-domain transcription factors to stimulate expression of target genes. In addition to the components of the Wnt/β-catenin pathway described here, many additional proteins with potential roles in regulating Wnt/β-catenin signaling have been reported including the phosphatase PP2A and the kinases Akt/protein kinase B, integrin-linked kinase (ILK), and PKC. **(b)** Signaling through the Wnt/Ca^2+^ pathway appears to involve activation of the two pertussis-toxin-sensitive G proteins, G~αo~ and G~.αt~, in combination with G~β2~ \[34,35\]. G-protein activation then leads to an increase in intracellular Ca^2+^ and the subsequent stimulation of Ca^2+^/calmodulin-dependent kinase II (CamKII) \[37\]. Activation of the Wnt/Ca^2+^ pathway also results in stimulation of PKC activity in the form of the translocation of PKC to the plasma membrane \[34\]. Downstream targets of the Wnt/Ca2^+^ pathway have not been identified. **(c)** The Wnt/polarity pathway, which regulates cytoskeletal organization; the *Drosophila* Wnt/polarity pathway that regulates the polarity of trichomes in the wing is shown as an example. In this case, the nature of the polarity signal is not known.](gb-2001-3-1-reviews3001-3){#F3}

The Wnt/Ca^2+^ pathway involves an increase in intracellular Ca^2+^ and activation of PKC; it can be activated by a distinct group of Wnt ligands and Fzd receptors from those that activate other pathways, including Wnt5a, Wnt11 and Fzd2 (Figure [3b](#F3){ref-type="fig"}) \[[@B58],[@B61],[@B62]\]. The Wnt/Ca^2+^ pathway involves activation of a heterotrimeric G protein, an increase in intracellular Ca^2+^, and activation of calcium/calmodulin-regulated kinase II (CamKII) and PKC \[[@B34],[@B35],[@B37]\]. The downstream targets of CamKII and PKC are currently unknown, but it has been shown that activation of the Wnt/Ca^2+^ pathway can antagonize the Wnt/β-catenin pathway in *Xenopus,* although it is unclear at what level this interaction occurs \[[@B65]\].

Wnt/polarity signaling regulates the polarity of cells through regulation of their cytoskeletal organization (Figure [3c](#F3){ref-type="fig"}) \[[@B56],[@B57],[@B62]\]. In vertebrates, Wnt/polarity signaling is thought to control polarized cell movements during gastrulation and neurulation \[[@B66],[@B67],[@B68],[@B69],[@B70]\]. In *Drosophila,* Wnt/polarity signaling is required for the appropriate orientation of trichomes - or hairs - of the adult wing and for appropriate chirality of ommatidia in the eye, and may regulate asymmetric cell divisions of certain neuroblasts \[[@B56],[@B71],[@B72]\]. The only molecules known to function in both the vertebrate and the invertebrate Wnt/polarity pathways are members of the Fzd family and the cytoplasmic scaffold protein Dsh. The regulation of gastrulation movements in vertebrates also requires the activity of *Wnt11,* which may signal through Fzd7 to regulate protrusive activity during convergent extension \[[@B66],[@B67]\]. In flies, genetic analyses have identified a number of potential components of the Wnt/polarity pathway in addition to DFzd1 and Dsh, including the small GTPase DrhoA, *Drosophila* rho-associated kinase (Drok), Jun N-terminal kinase (JNK), myosin II, myosin VIIA, and the products of the novel genes *flamingo/starry night, fuzzy, inturned,* and *strabismus/van gogh* \[[@B56],[@B72]\]. A Wnt ligand for the Wnt/polarity pathway has not been identified in flies, however, and it remains to be seen how much of the intracellular signaling mechanism has been conserved between vertebrates and invertebrates.

Several studies have suggested that distinct classes of Wnts signal through either the Wnt/β-catenin pathway or the Wnt/Ca^2+^ pathway \[[@B58]\]; for example, overexpression studies in *Xenopus* have shown that XWnt1, XWnt3a, XWnt8, and XWnt8b can stimulate the Wnt/β-catenin pathway whereas XWnt4, XWnt5a, and XWnt11 can stimulate the Wnt/Ca^2+^ pathway \[[@B58]\]. Furthermore, the separation of Wnts into these two distinct functional classes is mirrored by the classification of Fzd proteins into similar functional groups on the basis of their ability to activate one or other pathway in overexpression assays. Although this classification of Wnts, which partially mirrors their evolutionary relationships, may provide a useful tool for predicting the function of Wnts and Fzds, the relationship between specific Wnts and the intracellular pathway they use is not fixed. For example, overexpression of XWnt5a in combination with human FZD5 in *Xenopus* embryos results in activation of the Wnt/β-catenin pathway \[[@B73]\], suggesting that the activity of Wnts *in vivo* will be determined by the repertoire of Fzd receptors present at the cell surface.

Important mutants and developmental functions
---------------------------------------------

Loss-of-function mutations in 9 of the 18 mouse *Wnt* genes have been generated, and the phenotypes of mutant embryos demonstrate the diverse functions of *Wnt* genes during embryogenesis (Table [2](#T2){ref-type="table"}). For example, knocking out *Wnt1* results in a dramatic loss of a portion of the midbrain and deletion of the rostral cerebellum \[[@B74],[@B75]\]. Inactivation of *Wnt4* results in the absence of kidneys \[[@B76]\], masculinization of mutant females (absence of the Müllerian duct and continued development of the Wolffian duct) \[[@B77]\], and defects in mammary gland morphogenesis during pregnancy \[[@B78]\]. Targeted knockout of *Wnt7a* also has pleiotropic effects, including ventralization of the limbs \[[@B79]\], female infertility due to failure of Müllerian-duct regression \[[@B80]\], and a delay in the morphological maturation of glomerular rosettes in the cerebellum \[[@B81]\].

###### 

Developmental functions of mouse *Wnt* genes

  Gene       Natural allele          Phenotype of knockout or other functions                                                                     References
  ---------- ----------------------- ------------------------------------------------------------------------------------------------------------ -------------------
  *Wnt1*     *swaying*               Loss of a portion of the midbrain and cerebellum                                                             \[74,75,129,130\]
                                     Deficiency in dorsal neural-tube derivatives, including neural-crest cells in double knockout with *Wnt3a*   \[131\]
  *Wnt2*                             Placental defects                                                                                            \[132\]
  *Wnt3*                             Defects in axis formation and gastrulation                                                                   \[84\]
                                     Defects in hair growth and structure                                                                         \[133,134\]
  *Wnt3a*    *vestigial tail*        Defects in somite and tailbud development                                                                    \[102,135-137\]
                                     Deficiency in dorsal neural-tube derivatives, including neural crest cells in double knockout with *Wnt1*    \[131\]
                                     Loss of hippocampus                                                                                          \[138\]
  *Wnt4*                             Defects in kidney development                                                                                \[76\]
                                     Defects in female development; absence of Müllerian duct, ectopic synthesis of testosterone in females       \[77\]
                                     Defects in mammary gland morphogenesis                                                                       \[78\]
  *Wnt5a*                            Truncated limbs, shortened anterior-posterior axis, reduced number of proliferating cells                    \[139\]
  *Wnt7a*    *postaxial hemimelia*   Defects in limb polarity                                                                                     \[79\]
                                     Female infertility due to failure of Müllerian duct regression                                               \[80,140\]
                                     Defects in uterine patterning                                                                                \[141\]
                                     Defects in synapse maturation in the cerebellum                                                              \[81\]
  *Wnt7b*                            Placental defects                                                                                            \[142\]
  *Wnt10b*                           Inhibition of adipogenesis                                                                                   \[143\]

Overexpression and antisense \'knockdown\' analyses in *Xenopus* have shown that the Wnt/β-catenin pathway is required for the specification of dorsal cell fates \[[@B82]\]. A debate is ongoing, however, over whether a maternal Wnt ligand is required to activate this pathway in dorsal cells. In support of a role for a Wnt ligand, a recent study has shown that *XFzd7* is important for establishing dorsal cell fates \[[@B83]\], thereby implicating a Wnt ligand in this process. Furthermore, targeted knockout of *Wnt3* in mice results in defects in axis formation and gastrulation, suggesting a conserved role for Wnts in regulating the establishment of the dorsal-ventral axis in vertebrates \[[@B84]\]. On the other hand, overexpression of a dominant-negative form of *Xwnt8* in oocytes does not suppress formation of dorsal cell fates, arguing against the requirement for a maternal Wnt in axis specification \[[@B10]\]. Further studies are necessary to resolve the role of Wnts in vertebrate early axial development.

In flies, Wnt signaling has a variety of functions during development. The *wg* gene is required for cell-fate choices in the ventral epidermis during embryogenesis, as well as for many other functions, and *DWnt2* is required for testis and adult muscle development \[[@B17]\]. In *C. elegans,* genetic analyses have defined a number of roles for Wnts, including establishment of polarity and endodermal cell fates in the early embryo and regulation of cell migration, among many others \[[@B85]\]. A comprehensive list of *Wnt* genes and their mutant phenotypes in vertebrates and invertebrates can be found at the *Wnt* gene homepage \[[@B5]\].

Wnt signaling and cancer
------------------------

In addition to the many roles for Wnt signaling during development and in adult tissues, it is also involved in tumorigenesis in humans \[[@B59],[@B64]\]. Although mutation or misexpression of a *Wnt* gene has not been linked directly to cancer in humans, mutation of several intracellular components of the Wnt/β-catenin pathway is thought to be critical in many forms of cancer. Most notably, patients with familial adenomatous polyposis (FAP) develop multiple intestinal adenomas early in life and have germline mutations in the *APC* gene. In addition, mutation of *APC* is associated with more than 80% of sporadic colorectal adenomas and carcinomas. More than 95% of germline and somatic mutations of the *APC* gene are nonsense mutations that result in the synthesis of a truncated protein lacking the region of APC that is important for its function in the destruction complex. Significantly, these truncations in APC remove binding sites for β-catenin and Axin, as well as putative phosphorylation sites for GSK3; as a result, the mutant APC protein cannot efficiently promote degradation of β-catenin. Mutations in the third exon of the human β-catenin gene (*CTNNb1*) that make it refractory to phosphorylation-dependent degradation and lead to inappropriate accumulation of β-catenin have also been identified in a large number of primary human cancers (see \[[@B64]\] for a table of β-catenin mutations in human cancers). Interestingly, mutations in *CTNNb1* and *APC* are rarely found in the same tumor; for example, in colon cancer, in which the vast majority of tumors have mutations in *APC,* the overall frequency of *CTNNb1* mutations is relatively low, but colorectal tumors lacking *APC* mutations are much more likely to have mutations in *CTNNb1.* Recently, Axin has also been shown to act as a tumor suppressor; mutations in the *Axin1* gene have been found in human hepatocellular cancers \[[@B86]\]. Importantly, mutations in *Axin1* and *CTNNb1* found in hepatocellular carcinomas also show mutual exclusivity similar to that seen for *APC* and *CTNNb1* in colon cancers. Together, these data strongly argue that mutations resulting in the stabilization of β-catenin can promote cancer in many tissue types.

Frontiers
=========

The large number of *Wnt* genes and the many roles that Wnt signaling plays in development and human disease pose many unresolved issues for researchers. One of the major unanswered questions is the specificity of interactions between different Wnt ligands and Fzd receptors and also which downstream pathways these many different ligand-receptor pairs stimulate. It also remains unclear how Wnt signals are transduced by the Fzd-LRP receptor complex and what role proteoglycans play in this process. Inside the cell, many questions regarding the transduction of Wnt signals remain, including how receptor activation stimulates Dsh and how Dsh discriminates between different Wnt signals to activate either the Wnt/β-catenin or the Wnt/polarity pathway. Furthermore, many roles of *Wnts* during development remain to be determined. This challenge will require detailed analyses of knockout mice, in addition to biochemical, cell-biological and genetic analyses in other model systems, to characterize the functions of Wnts and the signaling pathways they use during embryogenesis. Finally, the identification and characterization of mutations in Wnt-pathway genes involved in human disease is ongoing and these studies, together with a greater knowledge of the molecular mechanism of Wnt signal transduction, promise future clinical therapies for devastating human afflictions such as colon cancer. Thus, although there is so much still to learn, the importance and widespread occurrence of Wnt signaling guarantees the rapid increase in our understanding of the normal and abnormal functions of the Wnts.
